Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

29.6%

8 terminated/withdrawn out of 27 trials

Success Rate

65.2%

-21.3% vs industry average

Late-Stage Pipeline

11%

3 trials in Phase 3/4

Results Transparency

13%

2 of 15 completed trials have results

Key Signals

2 recruiting2 with results6 terminated

Enrollment Performance

Analytics

N/A

13(59.1%)

Phase 2

4(18.2%)

Phase 1

2(9.1%)

Phase 3

2(9.1%)

Phase 4

1(4.5%)

22Total

N/A(13)

Phase 2(4)

Phase 1(2)

Phase 3(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials

NCT05289466Not ApplicableTerminated

Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation.

Role: lead

NCT04559893Not ApplicableCompleted

Collaboration Leading to Addiction Treatment and Recovery From Other Stresses

Role: collaborator

NCT04082611Not ApplicableCompleted

The PREVENTION Trial: Precision Recommendations to Optimize Neurocognition

Role: lead

NCT06794645Phase 2Recruiting

Pembrolizumab and Pemetrexed for Progressive Chordoma

Role: lead

NCT04634279Not ApplicableCompleted

Competitive Revision for CLARO: Collaboration Leading to Addiction Treatment and Recovery From Other Stresses

Role: collaborator

NCT04603209Recruiting

Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer

Role: lead

NCT03425292Phase 1Completed

A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer

Role: lead

NCT03069287Not ApplicableWithdrawn

Integrating Family Caregiver Support Into Cancer Clinical Trials

Role: lead

NCT03955042Phase 1Completed

Pemetrexed for the Treatment of Chordoma

Role: lead

NCT00297895Not ApplicableCompleted

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

Role: lead

NCT03709888Completed

Memantine XR and Pregabalin for Chemotherapy-Induced Peripheral Neuropathy

Role: lead

NCT00949312Unknown

Studying Lymph Nodes in Patients With Stage II Colon Cancer

Role: lead

NCT01861717Phase 4Terminated

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Role: lead

NCT02375984Phase 2Terminated

A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas

Role: lead

NCT03094741Not ApplicableCompleted

Evaluation of a Mobile Digital Solution for Cancer Care and Research

Role: lead

NCT03371147Not ApplicableCompleted

CancerLife: Patient-Driven Solution in Cancer Care

Role: lead

NCT03069105Completed

An Exploratory Study of Caregiver Burden Among Family Caregivers of Patients With Cancer

Role: lead

NCT02357498Not ApplicableCompleted

Transsphenoidal Extent of Resection Study

Role: collaborator

NCT02339987Terminated

Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration

Role: lead

NCT03097523Not ApplicableCompleted

Mitigating Cephalad Fluid Shifts: A NSBRI Study

Role: lead